Have a personal or library account? Click to login
Practice of iron chelation therapy for transfusion-dependent thalassemia in Southeast Asia Cover

Practice of iron chelation therapy for transfusion-dependent thalassemia in Southeast Asia

Asian Biomedicine
Volume 10 (2016): Issue 6 (December 2016)
By: Nurul Fatihah Azman,  Wan-Zaidah Abdullah,  Norsarwany Mohamad,  Rosnah Bahar,  Muhammad Farid Johan,  R. Diana,  Binti Hanafi Sarifah,  Surini Yusoff,  Ariffin Nasir,  Azizah Othman,  Surianti Sukeri,  Mohd Ismail Ibrahim,  Adil Hussein,  Rozita Hassan,  Padillah Yahya,  Rosline Hassan and  Bin Alwi Zilfalil  
Open Access
|Mar 2017

References

  1. 1De Silva S, Fisher C, Premawardhena A, Lamabadusuriya S, Peto T, Perera G, et al. Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations. The Lancet, 2000. 355(9206): p. 786-791.10.1016/S0140-6736(99)08246-X
    De SilvaSFisherCPremawardhenaALamabadusuriyaSPetoTPereraGThalassaemia in Sri Lanka: implications for the future health burden of Asian populationsThe Lancet20003559206786791
    Open DOIBack to article
  2. 2Weatherall DJ. Thalassaemias. In: eLS. Chichester: John Wiley and Sons; 2001. doi: 10.1002/9780470015 902.a0002274.pub2
    WeatherallDJThalassaemiasIn: eLSChichesterJohn Wiley and Sons2001doi: 10.1002/9780470015 902.a0002274.pub210.1002/9780470015902.a0005536.pub2
    Back to article
  3. 3Weatherall DJ, Clegg JB. The thalassaemia syndromes, 4th edition, Oxford: Blackwell Science; 2001. doi: 10.1002/9780470696705
    WeatherallDJCleggJBThe thalassaemia syndromes, 4th editionOxfordBlackwell Science2001doi: 10.1002/978047069670510.1002/9780470696705
    Back to article
  4. 4Fucharoen S, Winichagoon P. Prevention and control of thalassemia in Asia. Asian Biomed, 2010; 1:1-6.
    FucharoenSWinichagoonPPrevention and control of thalassemia in AsiaAsian Biomed2010116
    Back to article
  5. 5U.S. Department of Health and Human Services. International Thalassemia Awareness. Centers for Disease Control and Prevention [on line] 2016 [cited 2016 May 26], Available from: https://www.cdc.gov/features/international-thalassemia/index.html
    U.S. Department of Health and Human Services. International Thalassemia Awareness. Centers for Disease Control and Prevention [on line] 2016 [cited 2016 May 26]Available from: https://www.cdc.gov/features/international-thalassemia/index.html
    Back to article
  6. 6Thavorncharoensap M, Torcharus K, Nuchprayoon I, Riewpaiboon A, Indaratna K, Ubol BO. Factors affecting health-related quality of life in Thai children with thalassemia. BMC Hematol. 2010; 10:1. doi: 10.1186/1471-2326-10-1.10.1186/1471-2326-10-1
    ThavorncharoensapMTorcharusKNuchprayoonIRiewpaiboonAIndaratnaKUbolBOFactors affecting health-related quality of life in Thai children with thalassemiaBMC Hematol2010101doi: 10.1186/1471-2326-10-1283699220180983
    Open DOIBack to article
  7. 7Fucharoen S, Winichagoon P. Haemoglobinopathies in Southeast Asia. Indian J Med Res. 2011; 134: 498-506.22089614
    FucharoenSWinichagoonPHaemoglobinopathies in Southeast AsiaIndian J Med Res2011134498506
    Back to article
  8. 8Eleftheriou A, Angastiniotis M. A Report on Thalassaemia The Association of South East Asian Nations [ASEAN], 2013, Thalassaemia International Federation (TIF). p. 14.
    EleftheriouAAngastiniotisMA Report on Thalassaemia The Association of South East Asian Nations [ASEAN]2013Thalassaemia International Federation (TIF)14
    Back to article
  9. 9Balveer K, Pyar K, Wonke B, Combined oral and parenteral iron chelation in beta thalassaemia major. Med J Malaysia. 2000; 55: 493-7.11221163
    BalveerKPyarKWonkeBCombined oral and parenteral iron chelation in beta thalassaemia majorMed J Malaysia2000554937
    Back to article
  10. 10Fucharoen S, Winichagoon P. New updating into hemoglobinopathies. Int J Lab Hematol. 2012; 34: 559-65.2276234810.1111/j.1751-553X.2012.01446.x
    FucharoenSWinichagoonPNew updating into hemoglobinopathiesInt J Lab Hematol2012345596522762348
    Open DOIBack to article
  11. 11Galanello R, Origa R. Review: beta-thalassemia. Orphanet J Rare Dis. 2010; 5:1-15.
    GalanelloROrigaRReview: beta-thalassemiaOrphanet J Rare Dis2010511510.1186/1750-1172-5-11289311720492708
    Back to article
  12. 12Pedram M, Zandian K, Keikhaie B, Akramipour R, Hashemi A. Ghahfarokhi FK, et al. A report on chelating therapy and patient compliance by determination of serum ferritin levels in 243 thalassemia major patients. Iranian Journal of Pediatric Society. 2010; 2:65-9.
    PedramMZandianKKeikhaieBAkramipourRHashemiAGhahfarokhiFKA report on chelating therapy and patient compliance by determination of serum ferritin levels in 243 thalassemia major patientsIranian Journal of Pediatric Society20102659
    Back to article
  13. 13Schrier SL, Angelucci E. New strategies in the treatment of the thalassemias. Annu Rev Med. 2005; 56:157-71.10.1146/annurev.med.56.082103.10471815660507
    SchrierSLAngelucciENew strategies in the treatment of the thalassemiasAnnu Rev Med2005561577115660507
    Open DOIBack to article
  14. 14Nadarajan V. Modern management of thalassemia. ISBT Science Series. 2011; 6:432-7.10.1111/j.1751-2824.2011.01528.x
    NadarajanVModern management of thalassemiaISBT Science Series201164327
    Open DOIBack to article
  15. 15Ministry of Health, Malaysia. Management of Thalassaemia. Health Technology Assessment Unit. [on line] 2003 [cited 2016 Apr 14], p. 137, Available from: http://www.moh.gov.my/english.php/pages/view/199
    Ministry of Health, Malaysia. Management of Thalassaemia. Health Technology Assessment Unit.[on line] 2003 [cited 2016 Apr 14]137Available from: http://www.moh.gov.my/english.php/pages/view/199
    Back to article
  16. 16Sheth S. Iron chelation: an update. Curr Opin Hematol. 2014; 21:179-85.10.1097/MOH.000000000000003124504090
    ShethSIron chelation: an updateCurr Opin Hematol2014211798524504090
    Open DOIBack to article
  17. 17Shander A, Sazama K, Clinical consequences of iron overload from chronic red blood cell transfusions, its diagnosis, and its management by chelation therapy. Transfusion. 2010; 50:1144-55.10.1111/j.1537-2995.2009.02551.x20088842
    ShanderASazamaKClinical consequences of iron overload from chronic red blood cell transfusions, its diagnosis, and its management by chelation therapyTransfusion20105011445520088842
    Open DOIBack to article
  18. 18Kidson-Gerber GL, Francis S, Lindeman R. Management and clinical outcomes of transfusion-dependent thalassaemia major in an Australian tertiary referral clinic. Med J Aust. 2008; 188:72-5.
    Kidson-GerberGLFrancisSLindemanRManagement and clinical outcomes of transfusion-dependent thalassaemia major in an Australian tertiary referral clinicMed J Aust200818872510.5694/j.1326-5377.2008.tb01525.x
    Back to article
  19. 19Prabhu R, Prabhu V, Prabhu R. Iron overload in beta thalassemia - a review. J Biosci Tech. 2009; 1:20-31.
    PrabhuRPrabhuVPrabhuRIron overload in beta thalassemia - a reviewJ Biosci Tech200912031
    Back to article
  20. 20Wong C, Richardson DR. β-Thalassaemia: emergence of new and improved iron chelators for treatment. Int J Biochem Cell Biol. 2003; 35:1144-9.1267248410.1016/S1357-2725(03)00046-3
    WongCRichardsonDRβ-Thalassaemia: emergence of new and improved iron chelators for treatmentInt J Biochem Cell Biol20033511449
    Open DOIBack to article
  21. 21Crisponi G, Remelli M. Iron chelating agents for the treatment of iron overload. Coord Chem Rev. 2008; 252:1225-40.10.1016/j.ccr.2007.12.014
    CrisponiGRemelliMIron chelating agents for the treatment of iron overloadCoord Chem Rev2008252122540
    Open DOIBack to article
  22. 22Porter JB. Optimizing iron chelation strategies in P-thalassaemia major. Blood Rev. 2009; 23:S3-S7.10.1016/S0268-960X(09)70003-7
    PorterJBOptimizing iron chelation strategies in P-thalassaemia majorBlood Rev200923S3S7
    Open DOIBack to article
  23. 23Berdoukas V, Farmaki K, Wood JC, Coates T. Iron chelation in thalassemia: time to reconsider our comfort zones. Expert Rev Hematol. 2011; 4:17-26.10.1586/ehm.10.7421322775
    BerdoukasVFarmakiKWoodJCCoatesTIron chelation in thalassemia: time to reconsider our comfort zonesExpert Rev Hematol201141726
    Open DOIBack to article
  24. 24Ministry of Health, Malaysia, Management of transfusion dependent thalassaemia. Medical Development division: Putrajaya. [on line] 2009 [cited 2016 Apr 14]; pp. 1-99, Available from: http://www.mpaweb.org.my/file_dir/20755646044c43fcce36af5.pdf
    Ministry of Health, Malaysia, Management of transfusion dependent thalassaemia. Medical Development division: Putrajaya.[on line] 2009 [cited 2016 Apr 14]199Available from: http://www.mpaweb.org.my/file_dir/20755646044c43fcce36af5.pdf
    Back to article
  25. 25Thalassaemia International Federation, Thalassaemia Foundation of Thailand, and Mahidol University. 1st Pan-Asian conference on haemoglobinopathies. February 8-10, 2012. Bangkok, Thailand. Thalassemia Reports, 2012; 2 (s1):1-46. doi: 10.4081/thal.2012.s1.
    Thalassaemia International Federation, Thalassaemia Foundation of Thailand, and Mahidol University1st Pan-Asian conference on haemoglobinopathies. February 8-10, 2012Bangkok, ThailandThalassemia Reports20122(s1)146doi: 10.4081/thal.2012.s110.4081/thal.2012.s1
    Back to article
  26. 26Cianciulli P. Iron chelation therapy in thalassemia syndromes. Mediterranean Journal of Hematology and Infectious Diseases. 2009; 1:e2009034. doi: 10.4084/MJHID.2009.034.2141599910.4084/mjhid.2009.0034
    CianciulliPIron chelation therapy in thalassemia syndromesMediterranean Journal of Hematology and Infectious Diseases20091e2009034doi: 10.4084/MJHID.2009.034
    Open DOIBack to article
  27. 27Cappellini MD. Long-term efficacy and safety of deferasirox. Blood Rev. 2008; 22 (Suppl 2):S35-41.10.1016/S0268-960X(08)70007-919059055
    CappelliniMDLong-term efficacy and safety of deferasiroxBlood Rev200822(Suppl 2)S3541
    Open DOIBack to article
  28. 28Poggiali E, Cassinerio E, Zanaboni L, Cappellini MD. An update on iron chelation therapy. Blood Transfus. 2012; 10:411-22.22790257
    PoggialiECassinerioEZanaboniLCappelliniMDAn update on iron chelation therapyBlood Transfus20121041122
    Back to article
  29. 29Musallam KM, Angastiniotis M, Eleftheriou A, Porter JB. Cross-talk between available guidelines for the management of patients with betα-thalassemia major. Acta Haematol. 2013; 130:64-73.10.1159/00034573423485589
    MusallamKMAngastiniotisMEleftheriouAPorterJBCross-talk between available guidelines for the management of patients with betα-thalassemia majorActa Haematol2013130647323485589
    Open DOIBack to article
  30. 30Verissimo MPdA, Loggetto SR, Fabron Junior A, Baldanzi GR, Hamerschlak N, Fernandes JL, et al. Brazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusion. Rev Bras Hematol Hemoter. 2013; 35: 428-34.24478610
    VerissimoMPdALoggettoSRFabron JuniorABaldanziGRHamerschlakNFernandesJLBrazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusionRev Bras Hematol Hemoter2013354283410.5581/1516-8484.20130106390582624478610
    Back to article
  31. 31Cohen AR. New advances in iron chelation therapy. Hematology (ASH Education Book). 2006; 1:42-47.
    CohenARNew advances in iron chelation therapyHematology (ASH Education Book)20061424710.1182/asheducation-2006.1.4217124038
    Back to article
  32. 32Aimiuwu E, Thomas A. Roheemun N, Khairallah T, Georgiou A, Papadopoulou C. A guide for the haemoglobinopathy nurse. Nicosia (Cyprus): Thalassaemia International Federation; 2012.
    AimiuwuEThomasARoheemunNKhairallahTGeorgiouAPapadopoulouCA guide for the haemoglobinopathy nurseNicosia (Cyprus)Thalassaemia International Federation2012
    Back to article
  33. 33Vichinsky E. Iron overload and iron chelation therapy in pediatric patients. US Hematology. 2009; 2:64-7. doi: 10.17925/OHR.2009.02.0.64.
    VichinskyEIron overload and iron chelation therapy in pediatric patientsUS Hematology20092647doi: 10.17925/OHR.2009.02.0.6410.17925/OHR.2009.02.0.64
    Back to article
  34. 34Neufeld EJ. Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions. Blood. 2006; 107:3436-41.1662776310.1182/blood-2006-02-002394
    NeufeldEJOral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questionsBlood2006107343641189576516627763
    Open DOIBack to article
  35. 35Jamuar SS. Lai AH. Safety and efficacy of iron chelation therapy with deferiprone in patients with transfusion-dependent thalassemia. Ther Adv Hematol. 2012; 3: 299-307.2361691710.1177/2040620712450252
    JamuarSSLaiAHSafety and efficacy of iron chelation therapy with deferiprone in patients with transfusion-dependent thalassemiaTher Adv Hematol20123299307362731823616917
    Open DOIBack to article
  36. 36Naithani R, Chandra J, Sharma S. Safety of oral iron chelator deferiprone in young thalassaemics. Eur J Haematol. 2005; 74:217-20.1569379110.1111/j.1600-0609.2004.00377.x
    NaithaniRChandraJSharmaSSafety of oral iron chelator deferiprone in young thalassaemicsEur J Haematol2005742172015693791
    Open DOIBack to article
  37. 37Galanello R. Deferiprone in the treatment of transfusion-dependent thalassemia: a review and perspective. Ther Clin Risk Manag. 2007; 3:795-805.18473004
    GalanelloRDeferiprone in the treatment of transfusion-dependent thalassemia: a review and perspectiveTher Clin Risk Manag20073795805
    Back to article
  38. 38Jamuar SS, Lai AHM, Tan AM, Chan MY, Tan ES, Ng ISL. Use of deferiprone for iron chelation in patients with transfusion dependent thalassaemia. J Paediatr Child Health. 2011; 47:812-7.10.1111/j.1440-1754.2011.02031.x21902752
    JamuarSSLaiAHMTanAMChanMYTanESNgISLUse of deferiprone for iron chelation in patients with transfusion dependent thalassaemiaJ Paediatr Child Health201147812721902752
    Open DOIBack to article
  39. 39Cappellini DM, Cohen A, Porter J, Taher A, Viprakasit V, editors. Guidelines for the management of transfusion dependent thalassemia (TDT). 3rd ed. Nicosia (Cyprus): Thalassaemia International Federation; 2014.
    CappelliniDMCohenAPorterJTaherAViprakasitVeditorsGuidelines for the management of transfusion dependent thalassemia (TDT)3rd edNicosia (Cyprus)Thalassaemia International Federation2014
    Back to article
  40. 40Algren DA. Review of oral iron chelators (deferiprone and deferasirox) for the treatment of iron overload in pediatric patients. World Health Organization [on line] 2010 [cited 2016 Dec 01] pp. 1-22. Available from: http://www.who.int/selection_medicines/committees/expert/18/applications/OralIronChelators.pdf
    AlgrenDAReview of oral iron chelators (deferiprone and deferasirox) for the treatment of iron overload in pediatric patients. World Health Organization [on line] 2010 [cited 2016 Dec 01]122Available from: http://www.who.int/selection_medicines/committees/expert/18/applications/OralIronChelators.pdf
    Back to article
  41. 41Rachmilewitz EA, Giardina PJ. How I treat thalassemia. Blood. 2011; 118:3479-88.10.1182/blood-2010-08-300335
    RachmilewitzEAGiardinaPJHow I treat thalassemiaBlood201111834798821813448
    Open DOIBack to article
  42. 42Aydinok Y, Kattamis A, Viprakasit V Current approach to iron chelation in children. Br J Haematol. 2014; 165: 745-55.2464601110.1111/bjh.12825
    AydinokYKattamisAViprakasit V Current approach to iron chelation in childrenBr J Haematol20141657455524646011
    Open DOIBack to article
  43. 43Kwiatkowski JL. Real-world use of iron chelators. Hematology Am Soc Hematol Educ Program. 2011; 2011:451-58.22160073
    KwiatkowskiJLReal-world use of iron chelatorsHematology Am Soc Hematol Educ Program201120114515810.1182/asheducation-2011.1.45122160073
    Back to article
  44. 44Choudhry V, Naithani R. Current status of iron overload and chelation with deferasirox. Indian J Pediatr. 2007; 74:759-64.10.1007/s12098-007-0134-717785900
    ChoudhryVNaithaniRCurrent status of iron overload and chelation with deferasiroxIndian J Pediatr2007747596417785900
    Open DOIBack to article
  45. 45Maggio A, Filosa A, Vitrano A, Aloj G, Kattamis A, Ceci A, et al. Iron chelation therapy in thalassemia major: a systematic review with meta-analyses of 1520 patients included on randomized clinical trials. Blood Cells Mol Dis. 2011; 47:166-75.10.1016/j.bcmd.2011.07.00221843958
    MaggioAFilosaAVitranoAAlojGKattamisACeciAIron chelation therapy in thalassemia major: a systematic review with meta-analyses of 1520 patients included on randomized clinical trialsBlood Cells Mol Dis2011471667521843958
    Open DOIBack to article
  46. 46Galanello R, Agus A, Campus S, Danjou F, Giardina PJ, Grady RW. Combined iron chelation therapy. Ann N Y Acad Sci. 2010; 1202:79-86.2071277710.1111/j.1749-6632.2010.05591.x
    GalanelloRAgusACampusSDanjouFGiardinaPJGradyRWCombined iron chelation therapyAnn N Y Acad Sci20101202798620712777
    Open DOIBack to article
  47. 47Sayani F, Warner M, Wu J, Wong-Rieger D, Humphreys K, Odame I. Guidelines for the clinical care of patients with thalassemia in Canada. Toronto: Anemia Institute for Research and Education. [on line] 2012 [cited 2016 Apr 14] Available from: http://www.thalassemia.ca/wp-content/uploads/Thalassemia-Guidelines_ LR.pdf
    SayaniFWarnerMWuJWong-RiegerDHumphreysKOdameIGuidelines for the clinical care of patients with thalassemia in Canada. Toronto: Anemia Institute for Research and Education. [on line] 2012 [cited 2016 Apr 14]Available from: http://www.thalassemia.ca/wp-content/uploads/Thalassemia-Guidelines_ LR.pdf
    Back to article
  48. 48Kremastinos DT, Farmakis D. Iron overload cardiomyopathy in clinical practice. Circulation. 2011; 124:2253-63.10.1161/CIRCULATIONAHA.111.05077322083147
    KremastinosDTFarmakisDIron overload cardiomyopathy in clinical practiceCirculation201112422536322083147
    Open DOIBack to article
  49. 49Vichinsky E, Neumayr L, Trimble S, Giardina PJ, Cohen AR, Coates T, et al., Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME). Transfusion. 2014; 54:972-81.10.1111/trf.1234823889533
    VichinskyENeumayrLTrimbleSGiardinaPJCohenARCoatesTTransfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME)Transfusion20145497281441083523889533
    Open DOIBack to article
  50. 50Viprakasit V, Gattermann N, Lee JW, Porter JB, Taher AT, Habr D, et al. Geographical variations in current clinical practice on transfusions and iron chelation therapy across various transfusion-dependent anaemias. Blood Transfus. 2013; 11:108-22.22871821
    ViprakasitVGattermannNLeeJWPorterJBTaherATHabrDGeographical variations in current clinical practice on transfusions and iron chelation therapy across various transfusion-dependent anaemiasBlood Transfus20131110822
    Back to article
  51. 51Ngim CF, Ibrahim H, Lai NM, Ng C. A single centre study on birth of children with transfusion dependent thalassaemia in Malaysia and reasons for ineffective prevention. Prenat Diagn. 2015; 35:51-9.10.1002/pd.448425156332
    NgimCFIbrahimHLaiNMNgCA single centre study on birth of children with transfusion dependent thalassaemia in Malaysia and reasons for ineffective preventionPrenat Diagn20153551925156332
    Open DOIBack to article
  52. 52Ngim CF, Lai NM, Ibrahim H, Ratnasingam V Attitudes towards prenatal diagnosis and abortion in a multiethnic country: a survey among parents of children with thalassaemia major in Malaysia. J Community Genet. 2013; 4:215-21.10.1007/s12687-012-0133-x
    NgimCFLaiNMIbrahimHRatnasingamVAttitudes towards prenatal diagnosis and abortion in a multiethnic country: a survey among parents of children with thalassaemia major in MalaysiaJ Community Genet2013421521366684223296641
    Open DOIBack to article
  53. 53Dahlui M, Hishamshah M, Rahman A, Aljunid S. Quality of life in transfusion-dependent thalassaemia patients on desferrioxamine treatment. Singapore Med J. 2009; 50:794-9.19710979
    DahluiMHishamshahMRahmanAAljunidSQuality of life in transfusion-dependent thalassaemia patients on desferrioxamine treatmentSingapore Med J2009507949
    Back to article
  54. 54Riewpaiboon A, Nuchprayoon I, Torcharus K, Indaratna K, Thavorncharoensap M, Ubol B-o. Economic burden of beta-thalassemia/Hb E and beta-thalassemia major in Thai children. BMC Res Notes. 2010; 3:29. doi: 10.1186/1756-0500-3-29.
    RiewpaiboonANuchprayoonITorcharusKIndaratnaKThavorncharoensapMUbolB-oEconomic burden of beta-thalassemia/Hb E and beta-thalassemia major in Thai childrenBMC Res Notes2010329doi: 10.1186/1756-0500-3-2910.1186/1756-0500-3-29283571920181056
    Back to article
  55. 55Singapore Department of Statistics. Population Trends 2014. Republic of Singapore. [on line] 2014 [cited 2016 Apr 14]. Available from: http://www.nas.gov.sg/archivesonline/data/pdfdoc/20141002003/notice_of_publication_-_population_trends_2014. pdf
    Singapore Department of Statistics. Population Trends 2014. Republic of Singapore. [on line] 2014 [cited 2016 Apr 14].Available from: http://www.nas.gov.sg/archivesonline/data/pdfdoc/20141002003/notice_of_publication_-_population_trends_2014. pdf
    Back to article
  56. 56Tan ES, Koh C, Law HY, Tan GP, Lai AHM, Ng ISL. Haemoglobin E-beta thalassemia in Singapore. Ann Acad Med Singapore. 2014; 43:331-3.25028144
    TanESKohCLawHYTanGPLaiAHMNgISLHaemoglobin E-beta thalassemia in SingaporeAnn Acad Med Singapore201443331310.47102/annals-acadmedsg.V43N6p331
    Back to article
  57. 57Viprakasit V, Lee-Lee C, Chong QT, Lin K-H, Khuhapinant A. Iron chelation therapy in the management of thalassemia: the Asian perspectives. Int J Hematol. 2009; 90: 435-45.1986260210.1007/s12185-009-0432-0
    ViprakasitVLee-LeeCChongQTLinK-HKhuhapinantAIron chelation therapy in the management of thalassemia: the Asian perspectivesInt J Hematol2009904354519862602
    Open DOIBack to article
  58. 58Thalassaemia International Federation. 2nd Pan-Asian Conference on Haemoglobinopathies 27-28 December 2015: JW Marriott Hanoi Hotel, Vietnam.
    Thalassaemia International Federation. 2nd Pan-Asian Conference on Haemoglobinopathies 27-28 December 2015JW Marriott Hanoi Hotel, Vietnam1108
    Back to article
  59. 59Health Technology Assessment Indonesia. Pencegahan Thalassemia 2009. [on line] 2010 [cited 2016 Apr 14]; p. 92, Available from: https://www.scribd.com/doc/52216165/Pencegahan-Thalassemia
    Health Technology Assessment Indonesia. Pencegahan Thalassemia 2009[on line] 2010 [cited 2016 Apr 14]92Available from: https://www.scribd.com/doc/52216165/Pencegahan-Thalassemia
    Back to article
  60. 60Ethnic Groups Philippines. Ethnic Groups of the Philippines. [on line] 2011 [cited 2016 Apr 14]; Available from: http://www.ethnicgroupsphilippines.com/
    Ethnic Groups Philippines. Ethnic Groups of the Philippines[on line] 2011 [cited 2016 Apr 14]; Available from: http://www.ethnicgroupsphilippines.com/
    Back to article
  61. 61Nguyen HN. AB035. Thalassemia in Vietnam. Ann Trans Med. 2015; 3(Suppl 2): AB035. doi: 10.3978/j.issn.2305-5839.2015.AB035.
    NguyenHNAB035Thalassemia in VietnamAnn Trans Med20153(Suppl 2)AB035doi: 10.3978/j.issn.2305-5839.2015.AB035
    Back to article
  62. 62Weatherall DJ. The challenge of haemoglobinopathies in resource poor countries. Br J Haematol. 2011; 154: 736-44.2172620710.1111/j.1365-2141.2011.08742.x
    WeatherallDJThe challenge of haemoglobinopathies in resource poor countriesBr J Haematol20111547364421726207
    Open DOIBack to article
  63. 63Weatherall DJ. Thalassemia as a global health problem: recent progress toward its control in the developing countries. Ann N Y Acad Sci. 2010; 1202:17-23.2071276710.1111/j.1749-6632.2010.05546.x
    WeatherallDJThalassemia as a global health problem: recent progress toward its control in the developing countriesAnn N Y Acad Sci20101202172320712767
    Open DOIBack to article
  64. 64Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010; 115:4331-6.10.1182/blood-2010-01-25134820233970
    WeatherallDJThe inherited diseases of hemoglobin are an emerging global health burdenBlood201011543316288149120233970
    Open DOIBack to article
  65. 65Dhamcharee V, Romyanan O, Ninlagarn T. Genetic counseling for thalassemia in Thailand: problems and solutions. Southeast Asian J Trop Med Public Health. 2001;32: 413-8.11556598
    DhamchareeVRomyananONinlagarnTGenetic counseling for thalassemia in Thailand: problems and solutionsSoutheast Asian J Trop Med Public Health2001324138
    Back to article
  66. 66Issaragrisil S. Stem cell transplantation for thalassemia. Int J Hematol. 2002; 76:307-9.1243086910.1007/BF03165269
    IssaragrisilSStem cell transplantation for thalassemiaInt J Hematol200276307912430869
    Open DOIBack to article
  67. 67Vichinsky E, Levine L, Bhatia S, Bojanowski J, Coates T, Levine M (editor), et al. Standards of care guidelines for thalassemia 2012. Oakland, CA: Children’s Hospital and Research Center Oakland. [on line] 2012 [cited 2016 Apr 14] p. 28, Available from: http://thalassemia.com/documents/socguidelines2012.pdf
    VichinskyELevineLBhatiaSBojanowskiJCoatesTLevineM(editor)Standards of care guidelines for thalassemia 2012Oakland, CAChildren’s Hospital and Research Center Oakland[on line] 2012 [cited 2016 Apr 14]28Available from: http://thalassemia.com/documents/socguidelines2012.pdf
    Back to article
  68. 68Taher A, Vichinsky E, Musallam K, Cappellini MD, Viprakasit V. Guidelines for the management of non transfusion dependent thalassemia (NTDT). Nicosia (Cyprus): Thalassaemia International Federation. [on line] 2013 [cited 2016 Apr 14]; pp. 1-120, Available from: http://thalassemia.com/documents/NTDT-TIF-guidelines.pdf
    TaherAVichinskyEMusallamKCappelliniMDViprakasitVGuidelines for the management of non transfusion dependent thalassemia (NTDT)Nicosia (Cyprus)Thalassaemia International Federation[on line] 2013 [cited 2016 Apr 14]1120Available from: http://thalassemia.com/documents/NTDT-TIF-guidelines.pdf
    Back to article
  69. 69Tan PHC, Hwang WYK, Goh YT, Tan PL, Koh LP, Tan CH, et al. Unrelated peripheral blood and cord blood hematopoietic stem cell transplants for thalassemia major. Am J Hematol. 2004; 75:209-12.1505481110.1002/ajh.20015
    TanPHCHwangWYKGohYTTanPLKohLPTanCHUnrelated peripheral blood and cord blood hematopoietic stem cell transplants for thalassemia majorAm J Hematol2004752091215054811
    Open DOIBack to article
  70. 70van Be T, van Binh T, Binh N, Tuan T, Nghia H, Hien B. Current status of hematopoietic stem cell transplantations in Vietnam. Bone Marrow Transplant. 2008; 42 (Suppl 1):S146-8.10.1038/bmt.2008.14518724291
    van BeTvan BinhTBinhNTuanTNghiaHHienBCurrent status of hematopoietic stem cell transplantations in VietnamBone Marrow Transplant200842(Suppl 1)S146818724291
    Open DOIBack to article
DOI: https://doi.org/10.5372/1905-7415.1006.524 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Journal RSS Feed
Language: English
Page range: 537 - 547
Published on: Mar 31, 2017
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:
Iron chelation therapy,
practice,
Southeast Asia,
thalassemia
Related subjects:
Medicine,
Assistive professions, nursing,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Clinical medicine, other

© 2017 Nurul Fatihah Azman, Wan-Zaidah Abdullah, Norsarwany Mohamad, Rosnah Bahar, Muhammad Farid Johan, R. Diana, Binti Hanafi Sarifah, Surini Yusoff, Ariffin Nasir, Azizah Othman, Surianti Sukeri, Mohd Ismail Ibrahim, Adil Hussein, Rozita Hassan, Padillah Yahya, Rosline Hassan, Bin Alwi Zilfalil, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 10 (2016): Issue 6 (December 2016)Next article